← All Alto Neuroscience, INC filings

Alto Neuroscience, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NYSE
ANRO
Alto Neuroscience, INC
S-1MEF: Alto Neuroscience Files for Additional Shares in Public Offering
Alto Neuroscience is registering an additional 1,541,000 shares of common stock for its public offering, including an underwriter's option.
NYSE
ANRO
Alto Neuroscience, INC
S-1/A: Alto Neuroscience Updates S-1 Filing, Adjusts Registration Fee for IPO
Alto Neuroscience files an amendment to its S-1 registration statement, primarily to update the filing fee table for its proposed IPO.
NYSE
ANRO
Alto Neuroscience, INC
S-1/A: Alto Neuroscience Files for IPO, Aiming to Revolutionize Psychiatry with Precision Medicine
Alto Neuroscience is seeking to go public, planning to use proceeds to advance its clinical-stage pipeline and precision psychiatry platform.
NYSE
ANRO
Alto Neuroscience, INC
S-1: Alto Neuroscience Files for IPO, Aiming to Revolutionize Psychiatry with Precision Medicine
Alto Neuroscience, a clinical-stage biopharmaceutical company, has filed for an IPO to advance its precision psychiatry platform and pipeline of personalized treatments for mental health conditions.